Browsing Harvard Medical School by Keyword "Acromegaly"
Now showing items 1-2 of 2
-
Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology
(BioMed Central, 2014)Background: The Theoretical Domains Framework (TDF) is a set of 14 domains of behavior change that provide a framework for the critical issues and factors influencing optimal knowledge translation. Considering that a ... -
Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry
(Springer US, 2013)Lanreotide depot (LD; commercial name Somatuline® Depot) is an injectable, extended-release formulation of the synthetic somatostatin analog (SSA) lanreotide. In recent clinical trials, LD was found to be suitable for self ...